US83601L1026
US83601L1026
Sotera Health Company
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.15B EUR | 5.07B EUR | 4.09B EUR | 5.02B EUR |
Enterprise Value | 7B EUR | 6.98B EUR | 6.05B EUR | 6.95B EUR |
Valuation Multiples | ||||
Trailing P/E | 31.68x | 30.98x | 34.71x | 55x |
Forward P/E | 16.78x | -- | -- | -- |
Price to Sales | 4.24x | 4.16x | 3.44x | 5.52x |
Price to Book | 7.74x | 7.61x | 6.57x | 8.28x |
EV/Revenue | 5.76x | 5.74x | 5.08x | 7.64x |
EV/EBITDA | 12.14x | 13.15x | 11.7x | 16.97x |
Price to FCF (P/FCF) | 33.47x | 44.94x | 42.22x | 44.17x |
EV/FCF | 45.46x | 61.9x | 62.42x | 61.15x |
FCF Yield | 2.99% | 2.23% | 2.37% | 2.26% |